Greenwich LifeSciences, Inc. (GLSI)
16.03
+0.55
(+3.55%)
USD |
NASDAQ |
Oct 23, 16:00
16.07
+0.04
(+0.25%)
After-Hours: 20:00
Greenwich LifeSciences EPS Diluted (Quarterly) : -0.2701 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2701 |
| March 31, 2026 | -0.3884 |
| December 31, 2025 | -0.5541 |
| September 30, 2025 | -0.3044 |
| June 30, 2025 | -0.2804 |
| March 31, 2025 | -0.2084 |
| December 31, 2024 | -0.6113 |
| September 30, 2024 | -0.2031 |
| June 30, 2024 | -0.202 |
| March 31, 2024 | -0.1923 |
| December 31, 2023 | -0.2138 |
| September 30, 2023 | -0.1862 |
| June 30, 2023 | -0.1267 |
| March 31, 2023 | -0.1654 |
| December 31, 2022 | -0.2207 |
| September 30, 2022 | -0.1808 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.0577 |
| March 31, 2022 | -0.1508 |
| December 31, 2021 | -0.1808 |
| September 30, 2021 | -0.0666 |
| June 30, 2021 | -0.0581 |
| March 31, 2021 | -0.0466 |
| December 31, 2020 | -0.0906 |
| September 30, 2020 | -0.0215 |
| June 30, 2020 | -0.0173 |
| March 31, 2020 | -0.0208 |
| December 31, 2019 | -0.0287 |
| September 30, 2019 | -0.0281 |
| June 30, 2019 | -0.218 |
| March 31, 2019 | -0.0127 |
| December 31, 2018 | -0.1325 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.949M |
| Total Expenses (Quarterly) | 3.949M |
| Enterprise Value | 226.42M |
| Earnings Yield | -9.46% |
| Normalized Earnings Yield | -9.463 |